Pharmaceutical Industry discussion, review, analysis, news and information. |
« Annan Urges Pharmaceutical Companies to Review Prices of AIDS Drugs | Main | BioProgress Registers HypoSalix Artificial Saliva Spray For Treatment of Xerostomia »
|
Jul30
|
 "We have targets. We are in active discussions. We are in active due diligence," Chief Financial Officer Stuart Grant told Reuters in a telephone interview following the release of forecast-beating quarterly earnings. A takeover target might be identified within 18 months, Serono focusing on companies with products already on the market or with products in late-stage development. Read the full story from Reuters. |
TrackBack URL for this entry:
« Annan Urges Pharmaceutical Companies to Review Prices of AIDS Drugs | Main | BioProgress Registers HypoSalix Artificial Saliva Spray For Treatment of Xerostomia »
Use these fast growing business social media sites to promote your business, feature your products, spotlight your business leaders, create links, and drive traffic back to your company site, all for free!
BIZZlogos - Add your logo - free link to your site| View Network Map Network Feed List (OPML) Know More Media Network Feed |
PharmaGazette is a member of the Know More Media network of business related blogs.
Here are some current headlines from some of our business publications:
ProductivityGoal | CallCenterScript |
AdHurl | TheBizofKnowledge |
LandingTheDeal | CustomersAreAlways |
HealthCareVox | BrainBasedBusiness |
TheInsurancePolicy | MarketingBlurb |
Write for us About us Contact Advertise Privacy Disclaimer
This weblog is licensed under a Creative Commons License.
Comment Preview